UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients
Clinical trial NCT00113919 · TERMINATED
Trial details
- NCT number
- NCT00113919
- Sponsor
- University of Arkansas
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2009-10-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.